Guo et al. analyzed the prognostic value of IRX1 methylation in squamous cell carcinoma of the lung (LUSQ) and reported that methylation of two CpG sites are significantly associated with the prognosis of LUSQ patients [18]. Here, IRX1 is linked to squamous cell lung carcinoma.